Publications by authors named "Carducci C"

Introduction: MRI examinations in the pediatric population require acquiring motionless images in the safest possible manner. At our institute, we have developed a protocol called "Good Practice" aimed at avoiding anesthesia in newborns and infants through the use of the "feed and wrap" technique, as well as preventing hospitalization for older children requiring anesthesia with an optimized sedation protocol. We evaluated this protocol in terms of patient safety, imaging quality, and parental satisfaction.

View Article and Find Full Text PDF

Phenylketonuria (PKU, OMIM 261600) is a genetic disorder caused by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH). If left untreated, PKU leads to systemic phenylalanine (Phe) accumulation, which can result in irreversible brain damage and intellectual disabilities. In the last 60 years, early and strict dietary restriction of phenylalanine (Phe) intake proved to prevent the severe clinical phenotype of untreated PKU.

View Article and Find Full Text PDF
Article Synopsis
  • The GCH1 gene produces an enzyme essential for making tetrahydrobiopterin (BH4), crucial for monoamine neurotransmitter production; deficiencies can lead to various forms of dystonia and developmental issues.
  • The study reviewed 45 patients with arGTPCH deficiency, identifying three main phenotypes: early-infantile encephalopathy, dystonia-parkinsonism, and late-onset dopa-responsive dystonia (DRD).
  • Early pharmacological treatment is vital for the first two phenotypes to mitigate serious neurodevelopmental damage, and genotype analysis may help in quicker diagnosis and assessment of clinical severity.
View Article and Find Full Text PDF

Hyperserotonemia is one of the most studied endophenotypes in autism spectrum disorder (ASD), but there are still no unequivocal results about its causes or biological and behavioral outcomes. This systematic review summarizes the studies investigating the relationship between blood serotonin (5-HT) levels and ASD, comparing diagnostic tools, analytical methods, and clinical outcomes. A literature search on peripheral 5-HT levels and ASD was conducted.

View Article and Find Full Text PDF
Article Synopsis
  • The MRPS36 gene is crucial for the 2-oxoglutarate dehydrogenase complex, which plays a significant role in the Krebs cycle, and defects in this gene lead to serious metabolic disorders including developmental delays and neurological issues.
  • Researchers studied two siblings with Leigh syndrome and identified a specific mutation in the MRPS36 gene that impacts enzyme function without affecting protein levels.
  • The findings suggest that MRPS36 mutations contribute to Leigh syndrome, with elevated plasma glutamate and glutamine potentially serving as biomarkers for this condition.
View Article and Find Full Text PDF

Congenital malformations of the eye represent a wide and heterogeneous spectrum of abnormalities that may be part of a complex syndrome or be isolated. Ocular malformation severity depends on the timing of the causative event during eye formation, ranging from the complete absence of the eye if injury occurs during the first weeks of gestation, to subtle abnormalities if the cause occurs later on. Knowledge of ocular malformations is crucial to performing a tailored imaging protocol and correctly reporting imaging findings.

View Article and Find Full Text PDF

Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare autosomal recessive neurometabolic disorder leading to severe combined serotonin, dopamine, norepinephrine, and epinephrine deficiency. We report on a female patient with borderline functioning and sporadic clear-cut focal to bilateral seizures from age 10 years. A neuropsychological assessment highlighted a mild impairment in executive functions, affecting attention span and visual-spatial abilities.

View Article and Find Full Text PDF

The undesirable buildup of ice can compromise the operational safety of ships in the Arctic to high-flying airplanes, thereby having a detrimental impact on modern life in cold climates. The obstinately strong adhesion between ice and most functional surfaces makes ice removal an energetically expensive and dangerous affair. Hence, over the past few decades, substantial efforts have been directed toward the development of passive ice-shedding surfaces.

View Article and Find Full Text PDF

Background And Objective: Neonatal screening and early treatment have changed the natural history of PKU, preventing severe neurological and intellectual disability. Nevertheless, the outcome of the disease in early-treated adult patients (ETPKU) is less than optimal, the predictive value of metabolic biomarkers is feeble, and the recommended levels of blood phenylalanine (Phe) for adulthood are controversial. A crucial question whose answer will improve our understanding and treatment of PKU is whether cognitive outcomes can be modulated by levels of Phe even in early-treated adults.

View Article and Find Full Text PDF
Article Synopsis
  • A study compared the effects of energy-enhanced PN and standard PN on blood AA levels in preterm very low birth weight newborns during their first two weeks of life.
  • Results showed no significant differences in AA levels at the start, but at 15 days, Cohort B had variations in specific AAs; however, multivariate analysis did not support these findings. Caution is recommended for high energy intake via PN due to potential side effects.
View Article and Find Full Text PDF

Aim: Concerns have been raised about possible neuropsychiatric sequelae of COVID-19. The objective of this study was to examine the plausibility of long-term mental health consequences of COVID-19 by assessing a sample of children after the resolution of the acute SARS-CoV-2 infection.

Method: As part of a systematic follow-up assessment of pediatric patients with COVID-19 conducted at two university children's hospitals, 50 children (56% males) aged 8 to 17 years (median 11.

View Article and Find Full Text PDF

Background: Hypoxic-ischemic encephalopathy (HIE) is a severe pathology, and no unique predictive biomarker has been identified. Our aims are to identify associations of perinatal and outcome parameters with morphological anomalies and ADC values from MRI. The secondary aims are to define a predictive ADC threshold value and detect ADC value fluctuations between MRIs acquired within 7 days (MR0) and at 1 year (MR1) of birth in relation to perinatal and outcome parameters.

View Article and Find Full Text PDF

Untreated phenylketonuria (PKU) patients and PKU animal models show hypomyelination in the central nervous system and white matter damages, which are accompanied by myelin basic protein (MBP) impairment. Despite many assumptions, the primary explanation of the mentioned cerebral outcomes remains elusive. In this study, MBP protein and mRNA expression on brains of wild type (WT) and phenylketonuric (ENU2) mice were analyzed throughout mice lifespan (14-60-180-270-360-540 post-natal days, PND).

View Article and Find Full Text PDF

Inherited disorders of biogenic amine metabolism are genetically determined conditions resulting in dysfunctions or lack of enzymes involved in the synthesis, degradation, or transport of dopamine, serotonin, adrenaline/noradrenaline, and their metabolites or defects of their cofactor or chaperone biosynthesis. They represent a group of treatable diseases presenting with complex patterns of movement disorders (dystonia, oculogyric crises, severe/hypokinetic syndrome, myoclonic jerks, and tremors) associated with a delay in the emergence of postural reactions, global development delay, and autonomic dysregulation. The earlier the disease manifests, the more severe and widespread the impaired motor functions.

View Article and Find Full Text PDF

Pathogenic variants in dopa decarboxylase (DDC), the gene encoding the aromatic l-amino acid decarboxylase (AADC) enzyme, lead to a severe deficiency of neurotransmitters, resulting in neurological, neuromuscular, and behavioral manifestations clinically characterized by developmental delays, oculogyric crises, dystonia, and severe neurologic dysfunction in infancy. Historically, therapy has been aimed at compensating for neurotransmitter abnormalities, but response to pharmacologic therapy varies, and in most cases, the therapy shows little or no benefit. A novel human DDC gene therapy was recently approved in the European Union that targets the underlying genetic cause of the disorder, providing a new treatment option for patients with AADC deficiency.

View Article and Find Full Text PDF

Background: The aim of this study was to record the current status of newborn bloodspot screening (NBS) for CF across Europe and assess performance.

Methods: Survey of representatives of NBS for CF programmes across Europe. Performance was assessed through a framework developed in a previous exercise.

View Article and Find Full Text PDF

Introduction: l-amino acid decarboxylase deficiency (AADCD) is an ultrarare autosomal recessive defect of biogenic amine synthesis that presents with early-onset encephalopathy progressing to severe neurological impairment and intellectual disability. We aimed to explore neurocognitive and behavioral profiles associated with AADCD and possible factors predicting outcome in more detail.

Methods: Nine AADCD patients (23.

View Article and Find Full Text PDF
Article Synopsis
  • * The degree of brain damage is influenced by the type of infectious agent, its target cells, and the timing of maternal infection in relation to fetal brain development.
  • * New infectious agents like the Zika virus and SARS-CoV-2 have been linked to congenital brain damage, prompting increased focus on neuroimaging patterns related to these conditions in clinical settings.
View Article and Find Full Text PDF

Newborn screening (NBS) for inborn errors of metabolism is one of the most advanced tools for secondary prevention in medicine, as it allows early diagnosis and prompt treatment initiation. The expanded newborn screening was introduced in Italy between 2016 and 2017 (Law 167/2016; DM 13 October 2016; DPCM 12-1-2017). A total of 1,586,578 infants born in Italy were screened between January 2017 and December 2020.

View Article and Find Full Text PDF

Background: Few studies have evaluated cognitive functioning and mental health in children and adolescents who contracted the SARS-CoV-2 infection. We investigated the prevalence and association of neuropsychological difficulties, psychological symptoms, and self-reported long-COVID complaints in a sample of adolescents.

Methods: Thirty-one adolescents infected by COVID-19 within 3-6 months prior to the assessment were included.

View Article and Find Full Text PDF
Article Synopsis
  • 3-Methylglutaconic aciduria type I (MGCA1) is a genetic condition affecting leucine breakdown, caused by mutations in the gene for an enzyme called MGH, impacting patients differently, from no symptoms to severe brain issues.
  • A 31-month-old girl was referred for early signs detected in newborn screening, showing elevated levels of specific metabolites related to MGCA1, but initial genetic tests didn’t confirm a diagnosis.
  • Further tests revealed decreased MGH activity and confirmed gene microdeletions, prompting treatment with levocarnitine and dietary changes; the patient showed mild symptoms, highlighting the need for interdisciplinary collaboration in diagnosing metabolic disorders.
View Article and Find Full Text PDF

Objective: The Advanced Hybrid Closed Loop (AHCL) systems have provided the potential to ameliorate glucose control in children with Type 1 Diabetes. The aim of the present work was to compare metabolic control obtained with 2 AHCL systems (Medtronic 780G system and Tandem Control IQ system) in a pediatric real-life clinical context.

Research Design And Methods: It is an observational, real-life, monocentric study; thirty one children and adolescents (M:F = 15:16, age range 7.

View Article and Find Full Text PDF

Here we report, for the first time, the engineering of human red blood cells (RBCs) with an entire metabolic pathway as a potential strategy to treat patients with guanidinoacetate methyltransferase (GAMT) deficiency, capable of reducing the high toxic levels of guanidinoacetate acid (GAA) and restoring proper creatine levels in blood and tissues. We first produced a recombinant form of native human GAMT without any tags to encapsulate into RBCs. Due to the poor solubility and stability features of the recombinant enzyme, both bioinformatics studies and extensive optimization work were performed to select a mutant GAMT enzyme, where only four critical residues were replaced, as a lead candidate.

View Article and Find Full Text PDF

Objective: To evaluate the six-month impact of the advanced automated functions of a closed-loop control (CLC) system (Control-IQ) and a virtual educational camp (vEC) on emotions and time in range (TIR) of children and adolescents with type 1 diabetes.

Methods: Children and their parents participated in a three-day vEC. Clinical, glucose, and emotion data were evaluated before, just after, and six months after the vEC.

View Article and Find Full Text PDF

Citrulline is a target analyte measured at expanded newborn screening (NBS) and its elevation represents a biomarker for distal urea cycle disorders and citrin deficiency. Altered ratios of citrulline with other urea cycle-related amino acids are helpful for the differential diagnosis. However, the use of cut-off values in screening programmes has raised the issue about the interpretation of mild elevation of citrulline levels detected at NBS, below the usual range observed in the "classical/severe" forms of distal urea cycle disorders and in citrin deficiency.

View Article and Find Full Text PDF